We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -33.00 | -2.01% | 1,610.50 | 1,608.00 | 1,608.50 | 1,626.50 | 1,594.50 | 1,626.50 | 10,103,189 | 16:35:03 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.44 | 66.22B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 8829Y
GlaxoSmithKline PLC
13 May 2019
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 13 May 2019
Hot Features
Premium
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
--------------------------------------------------------
Period of return: From: 1 November 2018 To: 30 April 2019
------------------------ ------------------------- ------ ---------------------
Balance of unallotted securities under scheme(s) from
previous return: 547,331
--------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 0
--------------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): 393,607
--------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at
end of period: 153,724
--------------------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 13 May 2019
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline Share Option Plan - Ordinary Shares
--------------------------------------------------------
Period of return: From: 1 November 2018 To: 30 April 2019
------------------------ ------------------------- ------ ---------------------
Balance of unallotted securities under scheme(s) from
previous return: 2,223,352
--------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 0
--------------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): 958,344
--------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at
end of period: 1,265,008
--------------------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 13 May 2019
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline Share Option Plan - ADS
--------------------------------------------
Period of return: From: 1 November 2018 To: 30 April 2019
------------------------ ------------------- ----- ----------------
Balance of unallotted securities under scheme(s) from previous return: 7,336,096
--------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 0
--------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 1,424,800
--------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 5,911,296
--------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 13 May 2019
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline plc Share Save Plan 2012
---------------------------------------------
Period of return: From: 1 November 2018 To: 30 April 2019
------------------------ -------------------- ----- ----------------
Balance of unallotted securities under scheme(s) from previous return: 5,672,623
---------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 0
---------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 3,345,727
---------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 2,326,896
---------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BLRDMGMKVFMGLZM
(END) Dow Jones Newswires
May 13, 2019 12:44 ET (16:44 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
